Application 011145

Type
NDA
Sponsor
OAK PHARMS AKORN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
002DIURILCHLOROTHIAZIDETABLET;ORAL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
004DIURILCHLOROTHIAZIDETABLET;ORAL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
005DIURILCHLOROTHIAZIDE SODIUMINJECTABLE;INJECTIONEQ 500MG BASE/VIALYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N011145-002DIURILCHLOROTHIAZIDE500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982
N011145-004DIURILCHLOROTHIAZIDE250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982
N011145-005DIURILCHLOROTHIAZIDE SODIUMEQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**INJECTABLE / INJECTIONRLD, Approved before 1982

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 3 of 4 · 135 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2020-12-22 03:56 UTC2020-12N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19828869cabd3fbd…
2020-11-12 02:37 UTC2020-11N011145-002DIURIL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 1982c0c555d07b60…
2020-11-12 02:37 UTC2020-11N011145-004DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 1982c0c555d07b60…
2020-11-12 02:37 UTC2020-11N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982c0c555d07b60…
2019-12-14 00:12 UTC2019-12N011145-002DIURIL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 19823f01610625f2…
2019-12-14 00:12 UTC2019-12N011145-004DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 19823f01610625f2…
2019-12-14 00:12 UTC2019-12N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19823f01610625f2…
2019-09-15 20:21 UTC2019-09N011145-002DIURIL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 1982b00525d2431f…
2019-09-15 20:21 UTC2019-09N011145-004DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 1982b00525d2431f…
2019-09-15 20:21 UTC2019-09N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982b00525d2431f…
2019-07-19 19:46 UTC2019-07N011145-002DIURIL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 1982ea99ee380514…
2019-07-19 19:46 UTC2019-07N011145-004DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**TABLET / ORALRLD, Approved before 1982ea99ee380514…
2019-07-19 19:46 UTC2019-07N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N011145-002DIURIL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19826a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N011145-004DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19826a51e52b5d6a…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONRLD, Approved before 19826a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N011145-002DIURIL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19821c564ffb4f44…
2024-02-18 07:12 UTC2024-02N011145-004DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19821c564ffb4f44…
2024-02-18 07:12 UTC2024-02N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONRLD, Approved before 19821c564ffb4f44…
2023-12-20 04:57 UTC2023-12N011145-002DIURIL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N011145-004DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N011145-002DIURIL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N011145-004DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N011145-002DIURIL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19829b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N011145-004DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19829b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19829b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N011145-002DIURIL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N011145-004DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N011145-002DIURIL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19823f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N011145-004DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19823f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19823f0d92c62455…
2023-05-13 08:27 UTC2023-05N011145-002DIURIL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982053a50430f4f…
2023-05-13 08:27 UTC2023-05N011145-004DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 1982053a50430f4f…
2023-05-13 08:27 UTC2023-05N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 1982053a50430f4f…
2023-01-26 05:58 UTC2023-01N011145-002DIURIL500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19823bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01N011145-004DIURIL250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET / ORALRLD, Approved before 19823bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01N011145-005DIURILEQ 500MG BASE/VIALINJECTABLE / INJECTIONAPRLD, RS, Approved before 19823bdfa0b2c4d7…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N011145-005AP15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N011145-005AP15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N011145-005AP14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N011145-005AP174a2ff9319b5…
2022-03-09 01:35 UTC2022-03N011145-005AP1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N011145-005AP1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N011145-005AP187673890dc5c…
2021-03-12 10:30 UTC2021-03N011145-005AP15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N011145-005AP18869cabd3fbd…
2020-11-12 02:37 UTC2020-11N011145-005AP1c0c555d07b60…
2019-12-14 00:12 UTC2019-12N011145-005AP13f01610625f2…
2019-09-15 20:21 UTC2019-09N011145-005AP1b00525d2431f…
2019-07-19 19:46 UTC2019-07N011145-005AP1ea99ee380514…
2023-12-20 04:57 UTC2023-12N011145-005AP1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N011145-005AP1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N011145-005AP19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N011145-005AP1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N011145-005AP13f0d92c62455…
2023-05-13 08:27 UTC2023-05N011145-005AP1053a50430f4f…
2023-01-26 05:58 UTC2023-01N011145-005AP13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N011145-005AP13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N011145-005AP1f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N011145-005AP1e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N011145-005AP1cb3db0bc1861…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DIURILCHLOROTHIAZIDESalix Pharmaceuticals, Incbd936e35-1af8-42da-bcc0-f22489d685742021-11-01Warnings, Adverse reactionsName fallback
brand name: DIURIL
generic name: CHLOROTHIAZIDE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 10 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
17478-419Chlorothiazide SodiumChlorothiazide SodiumAkorn, Inc.NDA AUTHORIZED GENERICCurrent
17478-419Chlorothiazide SodiumChlorothiazide SodiumAkornNDA AUTHORIZED GENERICCurrent
17478-419Chlorothiazide SodiumChlorothiazide SodiumAkornNDA AUTHORIZED GENERICCurrent
17478-419Chlorothiazide SodiumChlorothiazide SodiumAkorn, Inc.NDA AUTHORIZED GENERICCurrent
17478-419Chlorothiazide SodiumChlorothiazide SodiumAkorn, Inc.NDA AUTHORIZED GENERICCurrent
76478-711Sodium Diurilchlorothiazide sodiumAkornNDACurrent
76478-711Sodium Diurilchlorothiazide sodiumOak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)NDACurrent
76478-711Sodium Diurilchlorothiazide sodiumOak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)NDACurrent
76478-711Sodium Diurilchlorothiazide sodiumAkornNDACurrent
76478-711Sodium Diurilchlorothiazide sodiumOak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.)NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
252SUPPL2005-08-11
251SUPPL2004-10-29
11922SUPPL2004-09-29
250SUPPL2004-09-29